-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: venture financing
Medical Innovation at Risk
The National Venture Capital Association’s MedIC Coalition recently released a report showing U.S. venture capitalists are decreasing their investments in biopharmaceutical and medical device companies, reducing their concentration in prevalent disease areas and shifting investments towards Europe and Asia. The report, Vital Signs: The Threat to Investment in U.S. Medical Innovation and the Imperative of FDA Reform, strongly indicates that America’s medical innovation economy is in grave danger of losing its primary source of funding, Read More >
Five things you need to know about the state of the industry
What is the state of the biotechnology industry? To find out where the it stands and what strategies you need to survive, read Ernst & Young’s 25th annual industry report, Beyond borders: global biotechnology report 2011, that was released during a super session at the 2011 BIO International Convention. What were the industry’s profits last year? What kind of companies received funding? How should you engage the regulators? What new competencies do you need to Read More >
Unleashing the Promise of Biotechnology to Cure Disease and Save Lives
The other day I came across an article discussing vaccinations and the author mentioned his 15-year-old son asking him: “Dad, what’s polio?” Many of us are old enough to remember a time when polio struck fear and caused suffering for millions. Today, at least in the developed world, polio is something kids have to ask their parents to explain to them. Imagine someday, our grandchildren asking us, “What was cancer?” How great would that be? Read More >
Are Manufacturers and Investors Looking for the Same Thing From Industrial Biotech?
The morning plenary session at BIO’s World Congress featured Jenny Cross from Mohawk Industries, makers of carpets, and Steven Mirshak of DuPont Tate & Lyle, suppliers of a biobased ingredient for Mohawk, discussing what consumers are looking for and how industrial biotech can meet their needs. Cross noted that their consumer research indicates that the typical consumer is looking for quality and durability, with price and “green” attributes coming second. One point that Cross emphasized Read More >
Biofuels Digest, BIO Launch Spring 2011 Bioenergy Business Outlook Survey
Biofuels Digest and the Biotechnology Industry Organization (BIO) invite the industry to take part in the Spring 2011 Bioenergy Business Outlook Survey. The survey examines growth expectations and opportunities from a company, national and organizational point of view. It also examines the role of research, government policy, finance, and research and market partners in creating opportunities or barriers to the growth of green jobs, energy security and reductions in greenhouse gas emissions. The survey is Read More >
